Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9
-
Amolyt Pharma Granted FDA Fast Track Designation for Eneboparatide for the Treatment of Hypoparathyroidism
-
Lisata Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update on Thursday, May 9, 2024
-
OTC Markets Group Announces Quarterly Index Performance and Rebalancing
-
Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer
-
Arbe to Participate at the Oppenheimer 9th Annual Emerging Growth Conference
-
EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024
-
Optimizing Application Connections and Improving Security Posture Among Top SD-WAN Deployment Drivers
-
60 Degrees Pharmaceuticals Receives FDA Comments on Tafenoquine-Babesiosis Clinical Trial Protocol; No Material Changes Required
-
CompTIA introduces new Data Advisory Council to help businesses foster data-driven culture
-
Subsea7: Subsea Integration Alliance collaboration agreement with Equinor; Commencing work on Wisting and Bay du Nord
-
Alliance Trust PLC - Net Asset Value
-
Avance Gas Holding Ltd: Invitation to Earnings Presentation for the First Quarter of 2024
-
CoreCard Corporation Reports First Quarter 2024 Results
-
Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76
-
VitalHub Announces Q1 2024 Conference Call Date
-
Parker Reports Fiscal 2024 Third Quarter Results
-
Stack Capital Group Inc. Reports Q1-24 Financial Results
-
Fireweed Engages ICP Securities Inc. for Automated Market Making Services
-
Notice of Knight Therapeutics' First Quarter 2024 Results Conference Call
-
Altimmune to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024
-
Aqua-Tots Swim School Prepares to Make A Splash In North Canton, Ohio
-
Clubhouse Media Group, Inc. Announces HoneyDrip.com Growth Results For April 2024
-
Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2024 Earnings and Company Updates
-
Biogen Reports Progress on Corporate Responsibility Priorities
-
AppTech Payments Corp. to Present at Sidoti Virtual Investor Conference May 8-9
-
MedBright AI Announces New Commercial Product Demos for MedMatrix AI Platform
-
FuelCell Energy and Toyota Motor North America Celebrate Launch of World's First "Tri-gen" Production System at the Port of Long Beach
-
Guangzhou Bio-gene Technologies Announces Initiation of Phase I Clinical Trial for BG1805, a CAR-T Targeting CLL-1
-
BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
-
Context Therapeutics Announces $100 Million Private Placement
-
GURU Organic Energy Enters Zero Sugar Segment With Metabolism-Boosting GURU Zero Wild Berry
-
MGP Ingredients Reports First Quarter 2024 Results
-
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
FuelCell Energy and Toyota Motor North America Celebrate Launch of World's First "Tri-gen" Production System at the Port of Long Beach
-
Quipt Home Medical Announces Normal Course Issuer Bid
-
The 2024 Xos SV Stepvan Now Available for Incentives on the HVIP Vehicle Catalog
-
Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting
-
Laureate Education Reports Financial Results for the First Quarter of 2024
-
Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024
-
Oma Savings Bank Plc: Manager´s Transactions – Jarmo Salmi
-
HUB Cyber Security Awarded Key Contract by the Israeli Airports Authority
-
MGP Ingredients Declares $0.12 Quarterly Dividend
-
Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024
-
INVNT GROUP and MSM Boost Partnership and Marketing Service Offerings in Motorsports Industry with Strategic Leadership Appointment
-
Ocugen Announces CSO to Present on Modifier Gene Therapy at Retina World Congress
-
Draganfly to Showcase Latest UAV Technology at Special Operations Forces Week 2024 - Booth #3701
-
Vivid Seats Releases 2024 Environmental, Social and Governance Update
-
HII Reports First Quarter 2024 Results
-
Alvotech Announces Participation at BofA Securities Healthcare Conference 2024
